Christy Tompkins
Psychiatric/Mental Health · Dublin, OHNPI 1942483201
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $964 and has fallen 69.6% since, to $293 in 2025.
Across 140 payments — averaging $20.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$447
- AbbVie$408
- Lundbeck LLC$369
- Teva Pharmaceuticals USA, Inc.$301
- Johnson & Johnson$274
- Axsome Therapeutics, Inc.$255
- plus $795 from 11 others
What the payments were for
- Food & beverage$2,849100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $447 |
| AbbVie | 27 | $408 |
| Lundbeck LLC | 22 | $369 |
| Teva Pharmaceuticals USA, Inc. | 16 | $301 |
| Johnson & Johnson | 9 | $274 |
| Axsome Therapeutics, Inc. | 7 | $255 |
| Neurocrine Biosciences, Inc. | 5 | $207 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $146 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $97 |
| Eisai Inc. | 4 | $72 |
| Bausch Health US, LLC | 4 | $64 |
| Alkermes, Inc. | 3 | $54 |
| Alfasigma USA, Inc. | 3 | $42 |
| Idorsia Pharmaceuticals US Inc | 2 | $32 |
| Masimo Corporation | 2 | $31 |
| Jazz Pharmaceuticals Inc. | 2 | $27 |
| Abbott | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,849 in reported general payments places this provider in the 80th percentile of 1,808 psychiatric/mental health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 26 | $1,074 |
| Duloxetine Hcl | 52 | $756 |
| Bupropion XlBupropion Hcl | 60 | $686 |
| Clonazepam | 56 | $369 |
| Nortriptyline Hcl | 11 | $358 |
| Fluoxetine Hcl | 14 | $194 |
| Sertraline Hcl | 23 | $150 |
| Trazodone Hcl | 26 | $144 |
| Buspirone Hcl | 13 | $142 |
| Zolpidem Tartrate | 25 | $97 |
| Lamotrigine | 20 | $85 |
| Lorazepam | 17 | $56 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Dublin
- Kadori MarshallDublin$21K
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Mary HallWarren$195K
- Kassandra KornbauCanfield$170K
- Steven MatesDayton$121K
- Robert ParsonsYoungstown$119K
- Chriscia BaneChillicothe$115K
- Rachael McLaughlinMaple Heights$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.